vs
Side-by-side financial comparison of Core Scientific, Inc. (CORZ) and Stoke Therapeutics, Inc. (STOK). Click either name above to swap in a different company.
Stoke Therapeutics, Inc. is the larger business by last-quarter revenue ($158.6M vs $79.8M, roughly 2.0× Core Scientific, Inc.). Core Scientific, Inc. runs the higher net margin — 268.5% vs 71.2%, a 197.3% gap on every dollar of revenue. On growth, Stoke Therapeutics, Inc. posted the faster year-over-year revenue change (3661.1% vs -16.0%). Stoke Therapeutics, Inc. produced more free cash flow last quarter ($131.7M vs $-450.8M).
Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.
Stoke Therapeutics, Inc. is a clinical-stage biotechnology company developing innovative RNA-targeted therapies for severe rare genetic diseases. Its lead candidates address unmet needs for Dravet syndrome, a rare epilepsy, and other neurological monogenic disorders, serving patients across North America and global markets.
CORZ vs STOK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.8M | $158.6M |
| Net Profit | $214.2M | $112.9M |
| Gross Margin | 26.0% | — |
| Operating Margin | -149.5% | 70.2% |
| Net Margin | 268.5% | 71.2% |
| Revenue YoY | -16.0% | 3661.1% |
| Net Profit YoY | 180.6% | 528.0% |
| EPS (diluted) | $-1.63 | $1.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.8M | — | ||
| Q3 25 | $81.1M | — | ||
| Q2 25 | $78.6M | — | ||
| Q1 25 | $79.5M | $158.6M | ||
| Q4 24 | $94.9M | $22.6M | ||
| Q3 24 | $95.4M | — | ||
| Q2 24 | $141.1M | — | ||
| Q1 24 | $179.3M | — |
| Q4 25 | $214.2M | — | ||
| Q3 25 | $-144.0M | — | ||
| Q2 25 | $-936.8M | — | ||
| Q1 25 | $576.3M | $112.9M | ||
| Q4 24 | $-265.5M | $-10.5M | ||
| Q3 24 | $-455.3M | — | ||
| Q2 24 | $-902.2M | — | ||
| Q1 24 | $210.7M | — |
| Q4 25 | 26.0% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | 27.5% | — | ||
| Q1 24 | 43.3% | — |
| Q4 25 | -149.5% | — | ||
| Q3 25 | -67.6% | — | ||
| Q2 25 | -33.4% | — | ||
| Q1 25 | -59.1% | 70.2% | ||
| Q4 24 | -41.9% | -60.4% | ||
| Q3 24 | -43.2% | — | ||
| Q2 24 | -64.3% | — | ||
| Q1 24 | 30.8% | — |
| Q4 25 | 268.5% | — | ||
| Q3 25 | -177.6% | — | ||
| Q2 25 | -1191.4% | — | ||
| Q1 25 | 724.6% | 71.2% | ||
| Q4 24 | -279.7% | -46.4% | ||
| Q3 24 | -477.4% | — | ||
| Q2 24 | -639.4% | — | ||
| Q1 24 | 117.5% | — |
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $-0.45 | — | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $1.24 | $1.90 | ||
| Q4 24 | $0.51 | $-0.15 | ||
| Q3 24 | $-1.17 | — | ||
| Q2 24 | $-5.05 | — | ||
| Q1 24 | $0.78 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $311.4M | $274.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-962.7M | $350.1M |
| Total Assets | $2.3B | $406.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $311.4M | — | ||
| Q3 25 | $453.4M | — | ||
| Q2 25 | $581.3M | — | ||
| Q1 25 | $697.9M | $274.8M | ||
| Q4 24 | $836.2M | $128.0M | ||
| Q3 24 | $253.0M | — | ||
| Q2 24 | $96.1M | — | ||
| Q1 24 | $98.1M | — |
| Q4 25 | $-962.7M | — | ||
| Q3 25 | $-1.3B | — | ||
| Q2 25 | $-1.2B | — | ||
| Q1 25 | $-308.8M | $350.1M | ||
| Q4 24 | $-943.0M | $229.0M | ||
| Q3 24 | $-826.7M | — | ||
| Q2 24 | $-1.2B | — | ||
| Q1 24 | $-318.5M | — |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.5B | $406.9M | ||
| Q4 24 | $1.5B | $271.6M | ||
| Q3 24 | $824.6M | — | ||
| Q2 24 | $664.2M | — | ||
| Q1 24 | $814.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.3M | $131.8M |
| Free Cash FlowOCF − Capex | $-450.8M | $131.7M |
| FCF MarginFCF / Revenue | -565.1% | 83.0% |
| Capex IntensityCapex / Revenue | 914.0% | 0.1% |
| Cash ConversionOCF / Net Profit | 1.30× | 1.17× |
| TTM Free Cash FlowTrailing 4 quarters | $-779.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.3M | — | ||
| Q3 25 | $131.8M | — | ||
| Q2 25 | $34.0M | — | ||
| Q1 25 | $-45.0M | $131.8M | ||
| Q4 24 | $42.9M | $-23.2M | ||
| Q3 24 | $5.7M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $22.2M | — |
| Q4 25 | $-450.8M | — | ||
| Q3 25 | $-112.7M | — | ||
| Q2 25 | $-87.3M | — | ||
| Q1 25 | $-129.0M | $131.7M | ||
| Q4 24 | $-52.1M | $-23.2M | ||
| Q3 24 | $-25.5M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-9.7M | — |
| Q4 25 | -565.1% | — | ||
| Q3 25 | -139.0% | — | ||
| Q2 25 | -111.0% | — | ||
| Q1 25 | -162.2% | 83.0% | ||
| Q4 24 | -54.8% | -102.7% | ||
| Q3 24 | -26.7% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -5.4% | — |
| Q4 25 | 914.0% | — | ||
| Q3 25 | 301.5% | — | ||
| Q2 25 | 154.2% | — | ||
| Q1 25 | 105.6% | 0.1% | ||
| Q4 24 | 100.0% | 0.2% | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | 1.30× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.08× | 1.17× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CORZ
| Other | $36.3M | 46% |
| Digital Asset Self Mining Service | $31.8M | 40% |
| Colocation Service | $11.6M | 15% |
STOK
Segment breakdown not available.
